retatrutide clinical trial news CT Health | Doctors are warning patients against using unapproved versions of retatrutide, an experimental Eli Lilly weight loss drug still in Is a new weight-loss drug

60,448 The typical oral dose is 250 mg daily, which is used for periods ranging from 3 weeks to 6 months

It is for laboratory research only and should be used by qualified personnel in certified facilities.

Opt-in to receive podcast show notes & follow-up information here

Health care providers can now report A1C results to patients using the same units (mg/dL or mmol/L) that patients see routinely in blood glucose measurements

Curr Obes Rep 10(4):458466 Rentzeperi E et al (2022) Sex Differences in response to treatment with glucagon-like peptide 1 receptor agonists: opportunities for a tailored approach to diabetes and obesity care